Slides
Page 1
1 NORMA GROUP Q3 2026 Results MAINTAL, November 3, 2026
Page 2
2 Disclaimer This presentation contains forward-looking statements on the business development of NORMA Group SE that are based on management’s current assumptions and judgments regarding future events and results. All statements in this presentation other than statements of historical fact could be forward-looking statements. Forward-looking statements generally are identified by words such as 'anticipates,' ‘believes,’ ‘estimates,’ ‘assume,’ ‘expects,’ ‘forecasts,’ ‘intends,’ ‘may,’, ‘could’ or ‘should,’ ‘will’, ‘continue,’ ‘future,’ opportunity,’ ‘plan,’ and similar expressions. Forward-looking statements are based on assumptions relating to the development of the economic, political and legal environment in individual countries, economic regions and markets, and in particular for the machine industry, which we have made on the basis of the information available to us and which we consider to be realistic at the time of publication. Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to known and unknown risks, uncertainties and other factors that are difficult to predict and out of our control. The financial position and profitability of NORMA Group SE and developments in the economic and regulatory environments may vary substantially (particularly on the down side) from those explicitly or implicitly assumed or described in these forward-looking statements. This presentation may include statistical and industry data provided by third parties. Any such data is taken or derived from information published by industry sources that NORMA Group SE believes to be credible and is included in this presentation to provide information on trends affecting the industry in which the NORMA Group SE operates. NORMA Group SE has not independently verified the third-party data, and makes no warranties as to its accuracy or completeness. The information in this presentation and any other material discussed verbally in connection with this presentation, including any forward-looking statements, is current only as of the date that it is dated or given. The Company disclaims any obligation to revise or update any such information for any reason, except as required by law. To the maximum extent permitted by law, neither NORMA Group SE nor any of its affiliates or their respective directors, officers, employees, consultants, agents or representatives shall be liable for any direct or indirect loss or damage whatsoever arising from any use of this presentation or otherwise arising in connection with it. ‘NewNORMA’ reflects the continuing operations in accordance with IFRS, while ‘Former NORMA’ includes both continuing and discontinued operations in accordance with IFRS.
Page 3
3 Sales growth in both strategic business units Double-digit organic growth in Industry Applications; slight growth in Mobility & New Energy NewNORMA execution supports profitability improvement Q3 2026 milestones | Delivering on NewNORMA priorities SALES PUSH 3.7% Q3 2026 adjusted EBIT Margin EUR 5.3m NewNORMA program savings in Q3 2026 Transformation Structural cost measures supporting margin recovery Business wins New business wins across strategic business units ACTIONS RESULTS & OUTLOOK ~€260m Shareholder return completed FY 2026 Outlook confirmed
Page 4
4 Sales Push delivering new business across both business units Q3 2026 business highlights | New orders in industrial and mobility applications IA: Expanding footprint in strategic focus industries • US: Components for diesel particulate filters in construction equipment • Europe: Specialized plastic lines for an existing client manufacturing off-road and agricultural machinery applications MNE: New order for an electrified vehicle platform of a Chinese OEM • Cooling applications for PHEV and BEV platforms • First entry into local vehicle platform • Expected lifetime sales >EUR 3m | SOP Q4 2026 Specialized plastic line application Illustrative product and installation rendering Cooling system connector for electrified vehicles Illustrative product rendering
Page 5
5 Slide 5 BESS APPLICATION Reliable thermal management required TECHNOLOGY TRANSFER Proven automotive technology adapted for BESS COMMERCIAL VALIDATION New customer win Battery thermal management Serviceable fluid connections SERIAL ORDERS received in 2026 7x per BESS unit CUSTOMER WIN Competitor replaced based on quality and engineering performance Implementation accelerated from Jan. 2027 to Aug. 2026 Automotive- grade quality Flow- optimized Modular solution Dry-Break technology successfully deployed in BESS* High quality and application engineering supported two new customer wins Technology transfer converts proven automotive engineering into new content and customer wins * BESS: Battery Energy Storage Systems
Page 6
6 Q3 2026: Organic growth and transformation support profitability Adjusted EBIT more than doubles to EUR 7.8m; adjusted EBIT margin expands by 1.8pp to 3.7% Net Sales* EUR 207.8m +4.2% YoY on comp. FX basis (+5.2% reported) Adjusted EBIT** EUR 7.8m +105.5% YoY Adjusted EBIT Margin** 3.7% +1.8pp YoY Net Operating Cash Flow EUR 10.2m Positive Q3 cash generation 207.8 197.5 Q3 2026 Q3 2025 7.8 3.8 Q3 2026 Q3 2025 3.7% 1.9% Q3 2026 Q3 2025 10.2 24.5 Q3 2026 Q3 2025 * Net sales represent reported IFRS revenue, including currency effects. ** For the adjustments, see slide 12. New (Q3 2026) & Former NORMANewNORMA NewNORMANewNORMA
Page 7
7 Q1-Q3 2026: Profitability recovery supports FY 2026 outlook Adjusted EBIT margin improves to 3.5%; adjusted EPS turns positive (EUR 0.05)* Net Sales** EUR 628.3m +0.9% YoY on comp. FX basis (-0.6% reported) Adjusted EBIT*** EUR 21.7m +269.3% YoY Adjusted EBIT Margin*** 3.5% +2.5pp YoY Net Operating Cash Flow EUR -2.9m EUR 62.0m below prior year 628.3 631.8 Q1-Q3 2026 Q1-Q3 2025 21.7 5.9 Q1-Q3 2026 Q1-Q3 2025 3.5% 0.9% Q1-Q3 2026 Q1-Q3 2025 -2.9 59.1 Q1-Q3 2026 Q1-Q3 2025 * Adjusted EPS refers to NewNORMA (Q1–Q3 2025: EUR -0.58) ** Net sales represent reported IFRS revenue, including currency effects. *** For the adjustments, see slide 12. Former NORMANewNORMA NewNORMANewNORMA
Page 8
8 Q3 2026 Top Line Development Net Sales up 4.2% YoY on comp. FX basis, primarily driven by volume growth Net Sales Bridge in EUR million NewNORMA incl. EUR 5.0m TSA specific sales to ADS incl. EUR 3.3m TSA specific sales to ADS 197.5 +7.0 +1.3 205.8 +2.0 207.8 Q3 2025 Volume Impact Price Impact Q3 2026 comp. FX Currency impact Q3 2026
Page 9
9 135.0 +1.2 136.3 +1.4 137.6 Q3 2025 Volume & Price impact Q3 2026 comp. FX Currency impact Q3 2026 Double-digit growth in Industry Applications; Mobility & New Energy slightly up Q3 2026 Net Sales Breakdown by Strategic Business Units Industry Applications Net Sales Bridge (in EUR million) Mobility & New Energy Net Sales Bridge (in EUR million) Net Sales: +11.3% YoY on comp. FX basis (+12.4% reported); incl. EUR 5.0m TSA-specific sales to ADS (Q3 2025: EUR 3.3m). Volume & Price: Driven by growth in the Americas, with positive contributions from EMEA and APAC. Currency impact: +1.1% YoY Net Sales: +0.9% YoY on comp. FX basis (+1.9% reported) Volume & Price: Supported by growth in the Americas and EMEA, partly offset by declining sales in APAC. Currency impact: +1.0% YoY NewNORMA NewNORMA 62.5 +7.0 69.5 +0.7 70.2 Q3 2025 Volume & Price impact Q3 2026 comp. FX Currency impact Q3 2026
Page 10
10 4.5% 8.4% Q3 2025 Q3 2026 30.4 28.7 10.3% 9.1% Q3 2025 Q3 2026 100.9 103.1 -0.9% 2.7% Q3 2025 Q3 2026 Mixed regional sales development; margin improvement in Americas and EMEA Q3 2026 Net Sales and Adj. EBIT Margin by Region * For the adjustments, see slide 12. Regional Adjusted EBIT margins based on total segment sales (incl. sales between segments) and excluding central costs of EUR 4.5m. ** Q3 2025: TSA specific sales to ADS of EUR 3.3m in Net sales and EUR 0.2m in Adj. EBIT AMERICAS EMEA APAC Net Sales +13.0% YoY on comp. FX (+14.8% reported) Adjusted EBIT* Margin +3.9pp YoY TSA specific sales to ADS (Q3 2026): EUR 5.0m in Net Sales and EUR 0.7m in Adj. EBIT** Net Sales +2.4% YoY on comp. FX ( +2.1% reported) Adjusted EBIT* Margin +3.6pp YoY Net Sales -9.0% YoY on comp. FX (-5.6% reported) Adjusted EBIT* Margin -1.2pp YoY Net Sales (in EUR million) and Adjusted EBIT Margin (in %)* NewNORMA 66.3 76.1
Page 11
11 Q3 2026 Adjusted EBIT Development NewNORMA transformation supports adjusted EBIT improvement to EUR 7.8m Adjusted EBIT Bridge in EUR Millions and % of Net Sales NewNORMA Transformation program delivered an overall positive net contribution of EUR 5.3m in Q3 2026 (Q1-Q3 2026: EUR 11.4m) 3.8 +3.8 -2.9 +1.0 +1.3 +0.3 +0.5 7.8 1.9% 3.7% Adj. EBIT Q3 2025Volume & Price Material Costs Personnel Costs Other OPEX D&A FX Adj. EBIT Q3 2026 NewNORMA
Page 12
12 Q1-Q3 2026 Operational Adjustments and Outlook FY 2026 in EUR million Reported Adjustments Q1-Q3 2026 Adjusted Adjustments FY 2026 Net Sales 628.3 — 628.3 EBITDA 39.1 16.7 • adjustments for transformation severance & project costs 55.8 approx. 24.0 • accelerated transformation severance & projects costs, partly pulled forward from 2027 EBITDA margin 8.9% EBIT 1.2 20.5 • as above • EUR 3.8 million amortization PPA 21.7 approx. 29.0 • as above • EUR ~5 million amortization PPA EBIT margin 3.5% Net Profit -13.3 15.1 • incl. EUR -5.5 million tax impact 1.7 Net Profit margin 0.3% EPS (in EUR) -0.46 0.51 0.05 NewNORMA
Page 13
13 NewNORMA generates positive net operating cash flow of EUR 10.2m Q3 2026 Cash Flow Development 18.8 -3.0 -0.8 -4.8 10.2 Adj. EBITDA Q3 2026 Change in supply chain financing programs* Other TWC change (excl. SCF)*Investments from operating business (CAPEX) Net Operating Cash Flow Net Operating Cash Flow in EUR million * Supply chain financing programs (factoring, ABS and reverse factoring): EUR 30.6m as of September 30, 2026 (June 30, 2026: EUR 33.7m). For further details on Trade Working Capital, see slide 25. NewNORMA
Page 14
14 FY 2026 Outlook FY 2025 Actuals Net Operating Cash Flow Net Sales Adjusted EBIT margin Outlook FY 2026 confirmed EUR 821.7m EUR 95.8m Growth in the range of around 0% to 2% In the range of around EUR 10m to around EUR 20m 0.8% In the range of around 2% to 4% Profitability recovery progressing in line with FY 2026 expectations
Page 15
15 Slide 15 NET SALES ADJUSTED EBIT MARGIN CASH CONVERSION1 ~1-3% CAGR FY26-31 >10% by FY31 >70%1 by FY31 Profitable growth in both SBUs Wave 1, Wave 2 and EMEA footprint to drive structural improvement Disciplined working capital management and capital expenditure Key Assumptions for Financial Ambition FY31 1 Cash Conversion is defined as adjusted EBIT plus D&A, less Capex, the change in trade working capital, and payment for taxes, divided by adjusted EBIT Stand-alone (organic development) Comparable geopolitical situation Comparable FX rates Comparable personnel cost inflation Stable energy & raw material prices NewNORMA sets a clear Financial Ambition for FY31 Assuming no major macro deterioration
Page 16
THANK YOU! Any Questions?
Page 17
Investor Relations Contact & Events Calendar Event Date Annual Report 2026 March 31, 2027 Interim Report Q1 2027 May 5, 2027 Annual Shareholders’ Meeting May 20, 2027 Interim Report Q2 2027 August 11, 2027 Interim Report Q3 2027 November 3, 2027 Contact Christian Filipcic, VP Global Marketing & Corporate Communications Mail: ir@normagroup.com
Page 18
Appendix
Page 19
19 Key Assumptions for Outlook 2026 Topline drivers Cashflow drivers • Outlook for key customer markets: ◦ Vehicle production: PC -0.4% YoY; CV +0.3% YoY1 ◦ Mechanical engineering: flat (+/-0%)2 ◦ Construction: Moderate growth: Europe +2%3, USA +1%4 • Outlook includes net sales of approx EUR 11m from business between IA and ADS in 2026 • Assume stable geopolitical impact (e.g. tariffs, supply chain interruptions) • Lower Net Op. Cashflow compared to FY 2025 (Former NORMA) from NewNORMA Operations following closing of WM sale • Assume lower absolute effects from supply chain financing programs following discontinuation of WM6 • Cash-related expenses from 2025 transformation costs Bottom-line drivers FX assumption • Base effect from approx. EUR 16m (non-adjusted) one-off costs in FY 20255 • Incremental effects of positive EUR 15m from transformation program (2025: EUR 4.5m) • Continued personnel cost inflation • Stable energy & raw material prices • Outlook for Net Sales, Adjusted EBIT Margin and Net Operating Cash Flow is based on stable FX rates (2026 average FX rate in line with 2025: EUR/USD 1.13, EUR/CNY 8.12) 1 S&P Global Mobility 2 VDMA 3 Euroconstruct / ifo Institut 4 FMI 5 EUR 16m one-offs including CEO change, Maintal D365 Implementation and Cyber-related costs 6 Supply chain financing programs (Factoring, ABS and Reverse Factoring Programs) of EUR 47.2m in FY2025 Assuming no major macro deterioration
Page 20
20 Outlook FY 2026 - Additional Housekeeping Items * 2025 supply chain financing programs (Factoring, ABS and Reverse Factoring Programs) of EUR 47.2m represented 4.4% of Former NORMA FY 2025 Net Sales of EUR 1,082.8m Transformation Costs D&A and Capex PPA amortization • Approx. EUR 24m P&L-effective transformation costs expected (to be adjusted) • Approx. EUR 15-20m cash-out related to transformation expected • Both approx. 5% of Net Sales • Approx. EUR 5m expected (to be adjusted) Supply Chain Financing Trade Working Capital • Lower in absolute terms as result of WM divest • Approx 3% to 4% of Last Twelve Months Net Sales* • Broadly stable as % of Net Sales (FY 2025: 20.4%) Interest Income Cash taxes • Positive Interest Income of approx. EUR 5m (net 1.5m) as result of Net Debt Free position, depending on interest rate development • Approx. EUR 10m
Page 21
21 Slide 21 Ongoing Wave 1 Additional Wave 2 Additional EMEA Footprint Total Program economics ~€38-42m Annual run-rate EBIT savings by FY28 ~€15m expected to be realized per year-end FY26 ~€28-32m Annual run-rate EBIT savings by FY28 ~€20-30m Annual run-rate EBIT savings by FY31 Implementation Costs ~€54-61m Cumulative P&L- effective costs by FY28 ~€56m expected to be incurred by year-end FY26 ~€15-20m Combined average annual P&L-effective costs 2027 - 2031 Incremental savings vs. baseline FY26 ~€23-27m additional annual run-rate EBIT savings vs. FY26 ~€48-62m Combined additional annual run-rate EBIT savings by FY31 vs. FY26 baseline Incremental run-rate EBIT savings vs. FY26 (Wave 1 remaining + Wave 2 + EMEA Footprint) ~€70-90m by FY31 Economics of NewNORMA Wave 2 and EMEA footprint build on the ongoing Wave 1 program
Page 22
22 Q3 2026 Profit & Loss Statement (NewNORMA) in EUR million and % Adjusted* Reported Q3 2025 Q3 2026 Q3 2025 Q3 2026 Net Sales 197.5 207.8 197.5 207.8 Gross Profit Gross Profit Margin 111.6 114.9 111.6 114.9 56.5% 55.3% 56.5% 55.3% Personnel Costs in % of sales -63.2 -64.4 -65.5 -71.6 32.0% 31.0% 33.2% 34.4% Other operating income and expenses in % of sales -33.1 -31.5 -34.3 -36.8 16.7% 15.1% 17.3% 17.7% EBITDA in % of sales 15.3 19.0 11.8 6.5 7.7% 9.2% 6.0% 3.1% EBIT in % of sales 3.8 7.8 -51.0 -6.0 1.9% 3.7% -25.8% (2.9)% Financial Result -4.3 1.4 -4.3 1.4 Profit before Tax -0.6 9.2 -55.4 -4.6 Taxes -3.6 -12.4 -2.3 -8.4 Net Profit -4.1 -3.3 -57.7 -13.0 * For further details of the adjustments, see slide 12.
Page 23
23 Q1-Q3 2026 Profit & Loss Statement (NewNORMA) in EUR million and % Adjusted* Reported Q1-Q3 2025 Q1-Q3 2026 Q1-Q3 2025 Q1-Q3 2026 Net Sales 631.8 628.3 631.8 628.3 Gross Profit Gross Profit Margin 349.5 352.3 349.5 352.0 55.3% 56.1% 55.3% 56.0% Personnel Costs in % of sales -207.2 -202.9 -209.9 -213.6 32.8% 32.3% 33.2% 34.0% Other operating income and expenses in % of sales -102.1 -93.6 -105.1 -99.4 16.2% 14.9% 16.6% 15.8% EBITDA in % of sales 40.2 55.8 34.5 39.1 6.4% 8.9% 5.5% 6.2% EBIT in % of sales 5.9 21.7 -54.1 1.2 0.9% 3.5% -8.6% 0.2% Financial Result -13.3 1.5 -13.3 1.5 Profit before Tax -7.4 23.3 -67.4 2.7 Taxes -11.0 -21.5 -8.4 -16.1 Net Profit -18.5 1.7 -75.8 -13.3 * For further details of the adjustments, see slide 12
Page 24
24 Sep 30, 2026 Balance Sheet in EUR million Sep 30, 2025 Sep 30, 2026 in EUR million Sep 30, 2025 Sep 30, 2026 Assets Equity and liabilities Non-current assets Equity Goodwill / Other intangible assets / Property, plant & equipment 418.9 403.8 Total equity 585.0 595.0 Non-current and current liabilities Other (non-)financial assets / Contract assets / Derivative financial assets / Deferred- and income tax assets 17.4 14.2 Retirement benefit obligations / Provisions 34.4 33.6 Borrowings and other financial liabilitiesTotal non-current assets 436.3 417.9 391.4 33.2 Current assets Other non-financial liabilities 43.2 47.7 Inventories 154.6 156.7 Contract liabilities 0.5 0.5 Other non-financial / other financial / derivative financial / income tax assets 36.8 59.4 Lease liabilities 23.0 26.6 Tax liabilities and derivative financial liabilities 22.2 73.0 Trade and other receivables 141.6 152.3 Trade payables 116.3 117.7 Cash and cash equivalents 111.8 141.0 Liabilities related to assets held for sale 83.2 — Assets held for sale 418.0 — Total current assets 862.8 509.3 Total liabilities 714.1 332.3 Total assets 1,299.1 927.3 Total equity and liabilities 1,299.1 927.3 Former NORMA
Page 25
25 Sep 30, 2026 Trade Working Capital Development Trade Working Capital increased from EUR 179.9 million to EUR 191.3 million, mainly driven by higher trade receivables. Trade Working Capital Ratio (as % of NewNORMA LTM Net Sales***) at 23.4% per Sep 30, 2026. Supply Chain Financing Programs** (in EUR million) 49.2 30.6 Supply Chain Financing Programs*** Sep 30, 2025 Sep 30, 2026 Supply Chain Financing Programs (SCF) reduced by around EUR 18.5 million mainly due to WM divestment. This represents 3.7% of NewNORMA LTM Net Sales*** per Sep 30, 2026. Expected FY 2026 level of SCF for continuing operations 3-4% of Net Sales *** NewNORMA LTM (Last Twelve Months) Net Sales of EUR 818.2 million per Sep 30, 2026; prior- year LTM NewNORMA base not available due to WM divestment and change in reporting perimeter Trade Working capital incl. Supply Chain Financing Programs* (in EUR million) 154.6 156.7 141.6 152.3 -116.3 -117.7 Inventories Trade receivablesTrade accounts payable Sep 30, 2025 Sep 30, 2026 * including non cash-effective additions to finance leases ** including Factoring, ABS and Reverse Factoring Programs NewNORMA
Page 26
26 Q3 2026 & Q1-Q3 2026 Cash Flow Development Former NORMA * Variance greater than 200% not reported. Net Operating Cash Flow and External Free Cash Flow in EUR million Q3 2025 Q3 2026 Variance Q1-Q3 2025 Q1-Q3 2026 Variance adj. EBITDA 31.8 18.8 -40.9% 96.1 58.6 -39.0% Δ ± Trade working capital 1.9 -3.8 n/a -11.2 -43.2 n/a Net operating cash flow before investments from operating business 33.7 15.0 -55.5% 84.9 15.4 -81.9% Δ ± Investments from operating business -9.3 -4.8 -48.4% -25.8 -18.4 -28.7% Net Operating Cash Flow 24.5 10.2 -58.4% 59.1 -2.9 -104.9% Payments for interest -7.3 -2.5 -65.8% -14.7 -7.9 -46.3% Payment for Tax -4.1 -34.2 n/a -16.3 -110.9 n/a Proceeds from/Repayments for derivatives 1.3 0.2 -84.6% 1.4 1.5 7.1% External Free Cash Flow 14.4 -26.3 n/a 29.5 -120.2 n/a